Healthcare Delivery · NSE · period ending 2026-03-31
Loading chart…
✓ Core business is permissible and non-compliant income is 2.1% of revenue (limit 5%).
| Ratio | Value | Limit | Result |
|---|---|---|---|
| Interest-bearing debt / market cap | 0% | < 30% | Pass |
| Interest-bearing investments / market cap | 0% | < 30% | Pass |
The underlying figures and the filing citations they came from are available with a free account.
Sign up free2.1% of any dividend from MEDANTA should be given to charity. Calculate your amount →
Compliance watch: verdict re-verified against live market cap on 13 Jun 2026 · rechecked every 6 hours · filings reviewed quarterly.
Moderate 3–6 month gains with a small 1-month rise and 50-day still below 200-day suggest a stock recovering from weakness and currently in a broad range. The distance from the 52-week high indicates room before prior peaks are challenged.
Computed from delayed price history and desk sentiment. Educational context only — not investment advice or a price prediction.